Anatara Lifesciences Ltd has released a press release.
APVMA approval for Detach
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Appendix 4E & Audited Financial Statements
- Investor Presentation and Strategy Update
- Anatara CEO announces retirement
- Exclusive Global License Agreement with Zoetis
- FDA approves the Human Food Safety Dossier
Later from Anatara Lifesciences
- Chief Executive Officer Appointment
- R&D Tax Refund Received
- Successful proof of concept studies
- Response to ASX Appendix 4C Query
- Anatara retains global market for Detach
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences